Presidential advisors Thursday (Sept. 18) recommended that the federal government create incentives for antibiotic drug development, including possible changes to reimbursement and patent buyouts -- a request that will be further evaluated by a new interagency task force created by an executive order. President Barack Obama signed the executive order and released a national strategy as part of a larger administration plan to combat antibiotic resistance that was generally met with support from industry and antibiotic experts. The call by...